s6y CAVANAUGH JAMES H 4

CAVANAUGH JAMES H 4, filed Apr 13, 2007: PRIMARY DOCUMENT

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
CAVANAUGH JAMES H

(Last) (First) (Middle)
C/O HEALTHCARE VENTURES LLC
44 NASSAU STREET

(Street)
PRINCETON NJ 08542

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ADVANCIS PHARMACEUTICAL CORP [ AVNC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
04/12/2007
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 04/12/2007 P 900,000(1) A $2.3637(2) 11,863,327(3) I(3) and Direct(3)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Warrant $2.3637(2) 04/12/2007 P 675,000(1) 04/12/2007 04/12/2012 Common Stock 675,000(1) $2.3637(2) 675,000(1) I(1) By Partnership(1)
Explanation of Responses:
1. These securities and warrants were purchased by HealthCare Ventures VI, L.P. ("HCVVI") and HealthCare Ventures VII, L.P. ("HCVVII"). The Reporting Person is a general partner of each of HealthCare Partners VI, L.P. ("HCPVI") and HealthCare Partners VII, L.P. ("HCPVII"), the general partners of each of HCVVI and HCVVII, respectively. The Reporting Person disclaims beneficial ownership in those securities in which he does not have a pecuniary interest, and this report shall not be deemed an admission that he is the beneficial owner of these securities for purposes of Section 16.
2. Represents the purchase price for a unit, each consisting of one share of the Issuer's common stock and a warrant to purchase 0.75 shares of the Issuer's common stock.
3. 3,629,973 of these securities are owned by HealthCare Ventures V, L.P. ("HCVV"); 6,215,389 of these securities are owned by HCVVI and 1,975,892 of these securities are owned by HCVII. The Reporting Person is a general partner of each of HealthCare Partners V, L.P. ("HCPV"), HCPVI and HCPVII, the general partners of each of HCVV, HCVVI and HCVII, respectively, and as such disclaims beneficial ownership in those securities in which he does not have a pecuniary interest, and this report shall not be deemed an admission that he is the beneficial owner of these securities for purposes of Section 16. ALSO INCLUDES 42,073 shares of Common Stock which are directly owned by the Reporting Person.
Remarks:
/s/Jeffrey Steinberg, Attorney-in-Fact for James Cavanaugh 04/12/2007
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.